Robert W. Hesslein Voyager Therapeutics, Inc. (VYGR) insider trading activity

Robert W. Hesslein is Senior VP & General Counsel of Voyager Therapeutics, Inc.. Currently has a direct ownership of 102,200 shares of VYGR, which is worth approximately $587,650. The most recent transaction as insider was on Mar 20, 2023, when has been sold 4,410 shares (Common Stock) at a price of $7.76 per share, resulting in proceeds of $34,221. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

0% 3M change

0% 12M change

Total Value Held $587,650

Robert W. Hesslein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2023	SELL Open market or private sale	$34,221 $7.76 p/Share	4,410 Reduced 4.14%	102,200 Common Stock
Feb 17 2023	SELL Open market or private sale	$24,562 $7.45 p/Share	3,297 Reduced 3.0%	106,610 Common Stock
Feb 13 2023	SELL Open market or private sale	$21,997 $7.67 p/Share	2,868 Reduced 2.54%	109,907 Common Stock
Jan 17 2023	SELL Open market or private sale	$21,792 $9.96 p/Share	2,188 Reduced 1.9%	112,775 Common Stock
Apr 04 2022	SELL Open market or private sale	$22,984 $8.25 p/Share	2,786 Reduced 2.37%	114,963 Common Stock
Mar 21 2022	SELL Open market or private sale	$42,068 $8.49 p/Share	4,955 Reduced 4.04%	117,749 Common Stock
Feb 17 2022	SELL Open market or private sale	$14,555 $3.55 p/Share	4,100 Reduced 3.23%	122,704 Common Stock
Feb 11 2022	SELL Open market or private sale	$10,927 $3.36 p/Share	3,252 Reduced 2.5%	126,804 Common Stock
Jan 13 2022	BUY Grant, award, or other acquisition	-	20,000 Added 13.33%	130,056 Common Stock
Apr 05 2021	BUY Open market or private sale	$16,295 $4.95 p/Share	3,292 Added 2.9%	110,056 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	30,000 Added 20.93%	113,348 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	34,000 Added 28.97%	83,348 Common Stock
Feb 11 2021	SELL Open market or private sale	$24,054 $7.55 p/Share	3,186 Reduced 6.06%	49,348 Common Stock

Also insider at

ALNY

ALNYLAM PHARMACEUTICALS, INC. Healthcare

EVP, CLO and Secretary

RWH